Judicial Interventions for IPRs in India
In Bayer Corporation Vs. Union of India (2009), the Court held that there is no Drug Patent Linkage mechanism in India and only the Controller of Patents has the authority to determine patent standards. It was also held that mere market approval of a drug does not lead to patent infringement and the jurisdiction of which does not lie with Drug authorities.
- Novartis v. Union of India & Others 2013, is a landmark decision by a two-judge bench of the Indian Supreme Court on the issue of whether Novartis could patent Gleevec, a cancer drug, in India. The Supreme Court case ....
Do You Want to Read More?
Subscribe Now
Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material before the last six months of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
Related Content
- 1 India’s Criminal Law Overhaul: Impact on Criminal Justice System
- 2 Fostering Decentralized Governance: Role of Sixth Schedule
- 3 Digitalization: A Game Changer for Local Governments
- 4 Discretionary Powers of Governors
- 5 Special Category States: Demand for Additional Finance
- 6 Significance of DPSP in promoting Social Justice in India
- 7 Financial Empowerment of PRIs: Measures and Challenges
- 8 Issues with Social dynamics
- 9 Suggestions for Delimitation Reforms
- 10 Issues with Delimitation
Constitution, Polity & Governance
- 1 Issues of IPR in India
- 2 National Intellectual Property Rights (IPR) Policy 2016
- 3 Treaties and Reciprocal Agreements Ratified by India
- 4 What is IPR?
- 5 Recent Government Initiatives for Civil Services Reforms
- 6 Accountability of Civil Servants to the Government
- 7 Responsibilities of the Civil Servants
- 8 Rights of the Civil Servants
- 9 Constitutional Provisions with Respect to Civil Servants
- 10 Examining the Utility of Article 142
- 11 Rights vs Duties
